Recent advances in exosome-mediated nucleic acid delivery for cancer therapy

Современные достижения в доставке нуклеиновых кислот с использованием экзосом для терапии рака
Xin Chen, Jia Liu, Chengbin Yang, Xinmeng Zhang, Haoqiang Huang, Qiqi Liu, Zhourui Xu, Ying Zhang, Shiqi Tang, Yujuan Chai, Meirong Li
2022-06-14

cancer therapyexosome-mediated nucleic acid deliveryextracellular vesiclesgene therapynucleic acid drugs
Cancer is a leading public health problem worldwide. Its treatment remains a daunting challenge, although significant progress has been made in existing treatments in recent years. A large concern is the poor therapeutic effect due to lack of specificity and low bioavailability. Gene therapy has recently emerged as a powerful tool for cancer therapy. However, delivery methods limit its therapeutic effects. Exosomes, a subset of extracellular vesicles secreted by most cells, have the characteristics of good biocompatibility, low toxicity and immunogenicity, and great designability. In the past decades, as therapeutic carriers and diagnostic markers, they have caught extensive attention. This review introduced the characteristics of exosomes, and focused on their applications as delivery carriers in DNA, messenger RNA (mRNA), microRNA (miRNA), small interfering RNA (siRNA), circular RNA (circRNA) and other nucleic acids. Meanwhile, their application in cancer therapy and exosome-based clinical trials were presented and discussed. Through systematic summarization and analysis, the recent advances and current challenges of exosome-mediated nucleic acid delivery for cancer therapy are introduced, which will provide a theoretical basis for the development of nucleic acid drugs.
1
Current challenges in exosome-mediated nucleic acid delivery are identified, providing a basis for developing nucleic acid therapeutics.
2
Exosomes may address poor specificity and low bioavailability that limit conventional cancer treatments and gene therapy delivery.
3
Exosomes offer biocompatible, low-toxicity, low-immunogenicity, and designable platforms for nucleic acid delivery in cancer therapy.
4
The review examines exosome-mediated delivery of DNA, mRNA, miRNA, siRNA, circular RNA, and other nucleic acids.
5
The review summarizes applications of exosome-based nucleic acid delivery in cancer therapy and discusses related clinical trials.

Exosome-mediated nucleic acid delivery systems for cancer therapy

The delivery-carrier properties, therapeutic applications, and current challenges of exosomes for transporting DNA, mRNA, miRNA, siRNA, circRNA, and other nucleic acids in cancer therapy

Publication Details
Publication Date
2022-06-14
Journal
Publisher
ISSN
Cited by
305
Access Type
Author Information
Authors
Xin Chen
Jia Liu
Chengbin Yang
Xinmeng Zhang
Haoqiang Huang
Qiqi Liu
Zhourui Xu
Ying Zhang
Shiqi Tang
Yujuan Chai
Meirong Li
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%